Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.
Identifieur interne : 001148 ( Main/Exploration ); précédent : 001147; suivant : 001149Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.
Auteurs : Napapan Kangwan [Corée du Sud] ; Jong Min Park [Corée du Sud] ; Ki Baik Hahm [Corée du Sud]Source :
- Current opinion in pharmacology [ 1471-4973 ] ; 2014.
Descripteurs français
- KwdFr :
- Agents protecteurs (pharmacologie), Agents protecteurs (usage thérapeutique), Animaux (MeSH), Anti-inflammatoires non stéroïdiens (effets indésirables), Anti-inflammatoires non stéroïdiens (pharmacologie), Anti-inflammatoires non stéroïdiens (usage thérapeutique), Humains (MeSH), Maladies intestinales (induit chimiquement), Maladies intestinales (prévention et contrôle), Maladies intestinales (traitement médicamenteux), Muqueuse gastrique (effets des médicaments et des substances chimiques), Salix (MeSH), Écorce (MeSH).
- MESH :
- effets des médicaments et des substances chimiques : Muqueuse gastrique.
- effets indésirables : Anti-inflammatoires non stéroïdiens.
- induit chimiquement : Maladies intestinales.
- pharmacologie : Agents protecteurs, Anti-inflammatoires non stéroïdiens.
- prévention et contrôle : Maladies intestinales.
- traitement médicamenteux : Maladies intestinales.
- usage thérapeutique : Agents protecteurs, Anti-inflammatoires non stéroïdiens.
- Animaux, Humains, Salix, Écorce.
English descriptors
- KwdEn :
- Animals (MeSH), Anti-Inflammatory Agents, Non-Steroidal (adverse effects), Anti-Inflammatory Agents, Non-Steroidal (pharmacology), Anti-Inflammatory Agents, Non-Steroidal (therapeutic use), Gastric Mucosa (drug effects), Humans (MeSH), Intestinal Diseases (chemically induced), Intestinal Diseases (drug therapy), Intestinal Diseases (prevention & control), Plant Bark (MeSH), Protective Agents (pharmacology), Protective Agents (therapeutic use), Salix (MeSH).
- MESH :
- chemical , adverse effects : Anti-Inflammatory Agents, Non-Steroidal.
- chemical , pharmacology : Anti-Inflammatory Agents, Non-Steroidal, Protective Agents.
- chemical , therapeutic use : Anti-Inflammatory Agents, Non-Steroidal, Protective Agents.
- chemically induced : Intestinal Diseases.
- drug effects : Gastric Mucosa.
- drug therapy : Intestinal Diseases.
- prevention & control : Intestinal Diseases.
- Animals, Humans, Plant Bark, Salix.
Abstract
Non-steroidal anti-inflammatory drugs (NSAIDs) have been used for analgesic, anti-inflammatory and antithrombotic actions and recently for cancer prevention, but they carries a risk of major gastroduodenal damages from symptomatic ulcers to serious complications leading to fatal outcomes. Therefore, the novel strategies to rescue long-term NSAID requiring patients from NSAID-associated gastroduodenal damages are essential. Besides of current drugs based on classic damaging mechanisms attributable to the decline of gastric mucosal prostaglandin synthesis, reductions of mucosal blood flow, attenuated bicarbonate secretion and mucus synthesis related with prostaglandin levels, effective therapeutics targeted for update mechanisms of NSAID-induced gastroduodenal damages are introduced in this paper based on recent advances in basic science and biotechnology exploring deeper molecular mechanisms of NSAID-induced gastroduodenal damage beyond COX inhibition.
DOI: 10.1016/j.coph.2014.06.003
PubMed: 24956584
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.</title><author><name sortKey="Kangwan, Napapan" sort="Kangwan, Napapan" uniqKey="Kangwan N" first="Napapan" last="Kangwan">Napapan Kangwan</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Park, Jong Min" sort="Park, Jong Min" uniqKey="Park J" first="Jong Min" last="Park">Jong Min Park</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Hahm, Ki Baik" sort="Hahm, Ki Baik" uniqKey="Hahm K" first="Ki Baik" last="Hahm">Ki Baik Hahm</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea; CHA University Bundang Medical Center, Digestive Disease Center, Seongnam 463-712, Republic of Korea. Electronic address: hahmkb@cha.ac.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea; CHA University Bundang Medical Center, Digestive Disease Center, Seongnam 463-712</wicri:regionArea><wicri:noRegion>Seongnam 463-712</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2014">2014</date><idno type="RBID">pubmed:24956584</idno><idno type="pmid">24956584</idno><idno type="doi">10.1016/j.coph.2014.06.003</idno><idno type="wicri:Area/Main/Corpus">001086</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001086</idno><idno type="wicri:Area/Main/Curation">001086</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001086</idno><idno type="wicri:Area/Main/Exploration">001086</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.</title><author><name sortKey="Kangwan, Napapan" sort="Kangwan, Napapan" uniqKey="Kangwan N" first="Napapan" last="Kangwan">Napapan Kangwan</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Park, Jong Min" sort="Park, Jong Min" uniqKey="Park J" first="Jong Min" last="Park">Jong Min Park</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081</wicri:regionArea><placeName><settlement type="city">Séoul</settlement><region type="capital">Région capitale de Séoul</region></placeName></affiliation></author><author><name sortKey="Hahm, Ki Baik" sort="Hahm, Ki Baik" uniqKey="Hahm K" first="Ki Baik" last="Hahm">Ki Baik Hahm</name><affiliation wicri:level="1"><nlm:affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea; CHA University Bundang Medical Center, Digestive Disease Center, Seongnam 463-712, Republic of Korea. Electronic address: hahmkb@cha.ac.kr.</nlm:affiliation><country xml:lang="fr">Corée du Sud</country><wicri:regionArea>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea; CHA University Bundang Medical Center, Digestive Disease Center, Seongnam 463-712</wicri:regionArea><wicri:noRegion>Seongnam 463-712</wicri:noRegion></affiliation></author></analytic><series><title level="j">Current opinion in pharmacology</title><idno type="eISSN">1471-4973</idno><imprint><date when="2014" type="published">2014</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals (MeSH)</term><term>Anti-Inflammatory Agents, Non-Steroidal (adverse effects)</term><term>Anti-Inflammatory Agents, Non-Steroidal (pharmacology)</term><term>Anti-Inflammatory Agents, Non-Steroidal (therapeutic use)</term><term>Gastric Mucosa (drug effects)</term><term>Humans (MeSH)</term><term>Intestinal Diseases (chemically induced)</term><term>Intestinal Diseases (drug therapy)</term><term>Intestinal Diseases (prevention & control)</term><term>Plant Bark (MeSH)</term><term>Protective Agents (pharmacology)</term><term>Protective Agents (therapeutic use)</term><term>Salix (MeSH)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Agents protecteurs (pharmacologie)</term><term>Agents protecteurs (usage thérapeutique)</term><term>Animaux (MeSH)</term><term>Anti-inflammatoires non stéroïdiens (effets indésirables)</term><term>Anti-inflammatoires non stéroïdiens (pharmacologie)</term><term>Anti-inflammatoires non stéroïdiens (usage thérapeutique)</term><term>Humains (MeSH)</term><term>Maladies intestinales (induit chimiquement)</term><term>Maladies intestinales (prévention et contrôle)</term><term>Maladies intestinales (traitement médicamenteux)</term><term>Muqueuse gastrique (effets des médicaments et des substances chimiques)</term><term>Salix (MeSH)</term><term>Écorce (MeSH)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term></keywords><keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term><term>Protective Agents</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Anti-Inflammatory Agents, Non-Steroidal</term><term>Protective Agents</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Intestinal Diseases</term></keywords><keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Gastric Mucosa</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Intestinal Diseases</term></keywords><keywords scheme="MESH" qualifier="effets des médicaments et des substances chimiques" xml:lang="fr"><term>Muqueuse gastrique</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Anti-inflammatoires non stéroïdiens</term></keywords><keywords scheme="MESH" qualifier="induit chimiquement" xml:lang="fr"><term>Maladies intestinales</term></keywords><keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Agents protecteurs</term><term>Anti-inflammatoires non stéroïdiens</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Intestinal Diseases</term></keywords><keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Maladies intestinales</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Maladies intestinales</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Agents protecteurs</term><term>Anti-inflammatoires non stéroïdiens</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Animals</term><term>Humans</term><term>Plant Bark</term><term>Salix</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Animaux</term><term>Humains</term><term>Salix</term><term>Écorce</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Non-steroidal anti-inflammatory drugs (NSAIDs) have been used for analgesic, anti-inflammatory and antithrombotic actions and recently for cancer prevention, but they carries a risk of major gastroduodenal damages from symptomatic ulcers to serious complications leading to fatal outcomes. Therefore, the novel strategies to rescue long-term NSAID requiring patients from NSAID-associated gastroduodenal damages are essential. Besides of current drugs based on classic damaging mechanisms attributable to the decline of gastric mucosal prostaglandin synthesis, reductions of mucosal blood flow, attenuated bicarbonate secretion and mucus synthesis related with prostaglandin levels, effective therapeutics targeted for update mechanisms of NSAID-induced gastroduodenal damages are introduced in this paper based on recent advances in basic science and biotechnology exploring deeper molecular mechanisms of NSAID-induced gastroduodenal damage beyond COX inhibition. </div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">24956584</PMID><DateCompleted><Year>2015</Year><Month>08</Month><Day>04</Day></DateCompleted><DateRevised><Year>2014</Year><Month>12</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1471-4973</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><PubDate><Year>2014</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Current opinion in pharmacology</Title><ISOAbbreviation>Curr Opin Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.</ArticleTitle><Pagination><MedlinePgn>17-23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.coph.2014.06.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1471-4892(14)00054-X</ELocationID><Abstract><AbstractText>Non-steroidal anti-inflammatory drugs (NSAIDs) have been used for analgesic, anti-inflammatory and antithrombotic actions and recently for cancer prevention, but they carries a risk of major gastroduodenal damages from symptomatic ulcers to serious complications leading to fatal outcomes. Therefore, the novel strategies to rescue long-term NSAID requiring patients from NSAID-associated gastroduodenal damages are essential. Besides of current drugs based on classic damaging mechanisms attributable to the decline of gastric mucosal prostaglandin synthesis, reductions of mucosal blood flow, attenuated bicarbonate secretion and mucus synthesis related with prostaglandin levels, effective therapeutics targeted for update mechanisms of NSAID-induced gastroduodenal damages are introduced in this paper based on recent advances in basic science and biotechnology exploring deeper molecular mechanisms of NSAID-induced gastroduodenal damage beyond COX inhibition. </AbstractText><CopyrightInformation>Copyright © 2014. Published by Elsevier Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kangwan</LastName><ForeName>Napapan</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jong Min</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hahm</LastName><ForeName>Ki Baik</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>CHA Cancer Prevention Research Center, CHA Cancer Institute, CHA University, Seoul 135-081, Republic of Korea; CHA University Bundang Medical Center, Digestive Disease Center, Seongnam 463-712, Republic of Korea. Electronic address: hahmkb@cha.ac.kr.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2014</Year><Month>06</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Curr Opin Pharmacol</MedlineTA><NlmUniqueID>100966133</NlmUniqueID><ISSNLinking>1471-4892</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000894">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020011">Protective Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000894" MajorTopicYN="Y">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005753" MajorTopicYN="N">Gastric Mucosa</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007410" MajorTopicYN="N">Intestinal Diseases</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D024301" MajorTopicYN="N">Plant Bark</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020011" MajorTopicYN="N">Protective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D032108" MajorTopicYN="N">Salix</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2014</Year><Month>05</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2014</Year><Month>06</Month><Day>01</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>8</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">24956584</ArticleId><ArticleId IdType="pii">S1471-4892(14)00054-X</ArticleId><ArticleId IdType="doi">10.1016/j.coph.2014.06.003</ArticleId></ArticleIdList></PubmedData></pubmed><affiliations><list><country><li>Corée du Sud</li></country><region><li>Région capitale de Séoul</li></region><settlement><li>Séoul</li></settlement></list><tree><country name="Corée du Sud"><region name="Région capitale de Séoul"><name sortKey="Kangwan, Napapan" sort="Kangwan, Napapan" uniqKey="Kangwan N" first="Napapan" last="Kangwan">Napapan Kangwan</name></region><name sortKey="Hahm, Ki Baik" sort="Hahm, Ki Baik" uniqKey="Hahm K" first="Ki Baik" last="Hahm">Ki Baik Hahm</name><name sortKey="Park, Jong Min" sort="Park, Jong Min" uniqKey="Park J" first="Jong Min" last="Park">Jong Min Park</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Bois/explor/WillowV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001148 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001148 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Bois
|area= WillowV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:24956584
|texte= Development of GI-safe NSAID; progression from the bark of willow tree to modern pharmacology.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:24956584" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a WillowV1
| This area was generated with Dilib version V0.6.37. |  |